New drug targets root cause of dangerous kidney disease in lupus patients
NCT ID NCT06064929
Summary
This early-stage study is testing the safety of an experimental drug called felzartamab in 14 people with lupus nephritis, a serious kidney disease caused by lupus. The drug is designed to target specific immune cells that cause harmful inflammation and damage in the kidneys. Researchers will monitor patients for side effects and check if the drug helps reduce protein in the urine and improve kidney function over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accurate Clinical Research - Katy
Katy, Texas, 77449, United States
-
CEMIC
CABA, Buenos Aires F.D., C1431FWO, Argentina
-
Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)
Montreal, Quebec, H2X 3J4, Canada
-
ClinCept, LLC/River City Vascular Specialists LLC
Columbus, Georgia, 31904, United States
-
Clinica Priv Velez Sarsfield
Córdoba, Córdoba Province, X5016, Argentina
-
Georgia Nephrology - Lawrenceville
Lawrenceville, Georgia, 30046, United States
-
Hospital Britanico de Buenos Aires
Caba, Buenos Aires F.D., C1280AEB, Argentina
-
Joseph S. and Diane H. Steinberg Ambulatory Care Center
Brooklyn, New York, 11201, United States
-
Monash Health
Melbourne, Victoria, 3168, Australia
-
Precision Comprehensive Clinical Research Solutions - Grapevine
Grapevine, Texas, 76051, United States
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Prolato Clinical Research Center
Houston, Texas, 77054, United States
-
R & H Clinical Research
Katy, Texas, 77450, United States
-
SUNY Downstate Medical Center
Brooklyn, New York, 11203, United States
-
St. Paul's Hospital
Vancouver, British Columbia, V6Z1Y6, Canada
-
Stanford University Medical Center
Stanford, California, 94305, United States
-
The Ohio State University (OSU)
Columbus, Ohio, 43210, United States
-
University Health Network - Toronto General Division
Toronto, Ontario, MST258, Canada
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of California, San Diego (UCSD)
La Jolla, California, 92037, United States
-
University of California, San Francisco (UCSF)
San Francisco, California, 94143, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Western Health
Saint Albans, Victoria, 3021, Australia
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.